Your browser doesn't support javascript.
loading
Low-dose administration of prednisone has a good effect on the treatment of prolonged hematologic toxicity post-CD19 CAR-T cell therapy.
Wang, Jiaxi; Zhang, Meng; Lyu, Hairong; Guo, Ruiting; Xiao, Xia; Bai, Xue; Pu, Yedi; Meng, Juanxia; Li, Qing; Yuan, Ting; Lu, Wenyi; Zhao, Mingfeng.
Afiliação
  • Wang J; Tianjin First Central Hospital, The First Central Clinical College of Tianjin Medical University, Tianjin, China.
  • Zhang M; Tianjin First Central Hospital, The First Central Clinical College of Tianjin Medical University, Tianjin, China.
  • Lyu H; Tianjin First Central Hospital, The First Central Clinical College of Tianjin Medical University, Tianjin, China.
  • Guo R; Tianjin First Central Hospital, The First Central Clinical College of Tianjin Medical University, Tianjin, China.
  • Xiao X; Tianjin First Central Hospital, The First Central Clinical College of Tianjin Medical University, Tianjin, China.
  • Bai X; Tianjin First Central Hospital, The First Central Clinical College of Tianjin Medical University, Tianjin, China.
  • Pu Y; Tianjin First Central Hospital, The First Central Clinical College of Tianjin Medical University, Tianjin, China.
  • Meng J; Tianjin First Central Hospital, The First Central Clinical College of Tianjin Medical University, Tianjin, China.
  • Li Q; Tianjin First Central Hospital, The First Central Clinical College of Tianjin Medical University, Tianjin, China.
  • Yuan T; Tianjin First Central Hospital, The First Central Clinical College of Tianjin Medical University, Tianjin, China.
  • Lu W; Tianjin First Central Hospital, The First Central Clinical College of Tianjin Medical University, Tianjin, China.
  • Zhao M; Tianjin First Central Hospital, The First Central Clinical College of Tianjin Medical University, Tianjin, China.
Front Immunol ; 14: 1139559, 2023.
Article em En | MEDLINE | ID: mdl-36999027
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China